Mexico Precision Medicine Market Analysis

Mexico Precision Medicine Market Analysis


$ 3999

Mexico Precision Medicine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Precision Medicine market is growing globally due to the advancements in genomics and molecular biology, increasing adoption of personalized therapies, rising prevalence of chronic diseases, the promise of improved patient outcomes, increasing rate of CNS Disorders such as Alzheimer's disease, epilepsy, multiple sclerosis, increasing partnerships between market players and higher technological advancements of precision medicine. Moderna, Inc., Personalis, Inc., CureVac SE, Celldex Therapeutics, BioNTech SE, Advaxis, Inc., Agenus Inc., Immatics Biotechnologies GmbH, Gritstone Oncology, ImmunityBio, Inc., bioMérieux SA, Bayer AG, Pfizer Inc., GSK plc, F. Hoffmann-La Roche Ltd. are the key market players involved in precision medicine market.

ID: IN10MXPH381 CATEGORY: Pharmaceuticals GEOGRAPHY: Middle East AUTHOR: Dr. Medha Sansanwal

Buy Now

Mexico Precision Medicine Market Analysis Summary

Mexico Precision Medicine Market is valued at around $803.9 Mn in 2022 and is projected to reach $2092.2 Mn by 2030, exhibiting a CAGR of 12.7% during the forecast period 2023-2030.

Precision medicine is a method of providing healthcare that customizes medical treatments and interventions to meet the unique needs of each patient by taking into account individual variances in genes, environment, and lifestyle. It entails identifying molecular and genetic traits that affect illness development and therapeutic response by using cutting-edge technologies including genomics, proteomics, and data analytics. A key principle involved in precision medicine are personalized approach as it recognizes that each individual is unique, based on the unique traits and requirements of the patient, it seeks to give customized treatments and interventions. Genomic Medicine which involves examining a person's genetic makeup to determine their propensity for specific diseases and forecast their response to various treatments. Integrated data analysis, targeted therapies, prevention, and early detection are also key principles. Moderna, Inc., Personalis, Inc., CureVac SE, Celldex Therapeutics, BioNTech SE, Advaxis, Inc., Agenus Inc., Immatics Biotechnologies GmbH, Gritstone Oncology, ImmunityBio, Inc., bioMérieux SA, Bayer AG, Pfizer Inc., GSK plc, F. Hoffmann-La Roche Ltd. are the key market players involved in precision medicine market.

Market Dynamics

Market Growth Drivers

Advancements in genomics and molecular biology, increasing adoption of personalized therapies, rising prevalence of chronic diseases, the promise of improved patient outcomes, increasing rate of CNS Disorders such as Alzheimer's disease, epilepsy, and multiple sclerosis, increasing partnerships between market players, and higher technological advancements of precision medicine. All these factors act as market growth drivers.

Market Restraints

High Cost of Precision medicine, Limited Data Availability, Ethical and Privacy Concerns, Regulatory and Reimbursement Challenges, and lack of skilled professionals. All these factors act as market growth restraints.

Competitive Landscape

Key Players

  • Moderna, Inc.
  • Personalis, Inc.
  • CureVac SE
  • Celldex Therapeutics
  • BioNTech SE
  • Advaxis, Inc.
  • Agenus Inc.
  • Immatics Biotechnologies GmbH
  • Gritstone Oncology
  • ImmunityBio, Inc.
  • bioMérieux SA
  • Bayer AG
  • Pfizer Inc.
  • GSK plc
  • F. Hoffmann-La Roche Ltd.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For Mexico Precision Medicine Market

By Application

  • Diagnostics
  • Therapeutics
  • Others

By Technology

  • Pharmacogenomics
  • Point-of-Care Testing
  • Stem Cell Therapy
  • Pharmacoproteomics
  • Others

By Indication

  • Oncology
  • Central Nervous System (CNS) Disorders
  • Immunology Disorders
  • Respiratory Disorders
  • Others

By Drugs

  • Alectinib
  • Osimertinib
  • Mepolizumab
  • Aripiprazole Lauroxil,
  • Others

By Route of Administration

  • Oral
  • Injectable

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up